Ming‐Kuei Jang

673 total citations
15 papers, 473 citations indexed

About

Ming‐Kuei Jang is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Ming‐Kuei Jang has authored 15 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Ming‐Kuei Jang's work include Alzheimer's disease research and treatments (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Ion channel regulation and function (3 papers). Ming‐Kuei Jang is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Ion channel regulation and function (3 papers). Ming‐Kuei Jang collaborates with scholars based in United States, Taiwan and Japan. Ming‐Kuei Jang's co-authors include Shelley J. Russek, David H. Farb, Dale F. Mierke, Makoto Higuchi, Terrell T. Gibbs, Paul Tempest, Yousuf Ali, Hui‐Chen Lu, Deepa V. Venkitaramani and Robia G. Pautler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The FASEB Journal.

In The Last Decade

Ming‐Kuei Jang

14 papers receiving 464 citations

Peers

Countries citing papers authored by Ming‐Kuei Jang

Since Specialization

Citations

This map shows the geographic impact of Ming‐Kuei Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Kuei Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Kuei Jang more than expected).

Fields of papers citing papers by Ming‐Kuei Jang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Kuei Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Kuei Jang. The network helps show where Ming‐Kuei Jang may publish in the future.

Co-authorship network of co-authors of Ming‐Kuei Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Kuei Jang. A scholar is included among the top collaborators of Ming‐Kuei Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Kuei Jang. Ming‐Kuei Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A unipolar-driven synaptic transistor for environment-adaptable vision system 2025 ·Nature Communications ·(unknown), (unknown), Chungryeol Lee, (unknown), Ming‐Kuei Jang, J. Park, (unknown), Junhwan Choi, Jung Ho Yoon, Sung Gap Im	3
2	High‐molecular‐weight oligomer tau ( HMWoTau ) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody ( APNmAb005 ) 2024 ·The FASEB Journal ·Hiroaki Fukumoto, (unknown), Chin‐Yin Tai, Ming‐Kuei Jang, Masaomi Miyamoto	5
3	Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects 2023 ·Annals of Nuclear Medicine ·Masaomi Miyamoto, Chio Okuyama, Shinya Kagawa, (unknown), Masaaki Takahashi, Keisuke Takahata, Ming‐Kuei Jang, Hiroshi Yamauchi	3
4	PROTAC tau degrader for the treatment of Alzheimer’s disease and primary tauopathies 2023 ·Alzheimer s & Dementia ·(unknown), Yen‐Ting Lai, Yih‐Shyan Lin, Mi Kyung Lee, (unknown), (unknown), Yuan Chai, Xiaojuan Wang, (unknown), (unknown), (unknown), Ming‐Kuei Jang, Paul Tempest	2
5	APNmAb005, an anti‐tau antibody targeting synaptic tau oligomers, in Phase 1 for treatment of Alzheimer’s Disease and primary tauopathies 2023 ·Alzheimer s & Dementia ·Chin‐Yin Tai, (unknown), (unknown), Meng Wu, (unknown), Chia‐Lin Wu, Yen‐Ting Lai, Geidy E. Serrano, Thomas G. Beach, Richard Margolin, (unknown), Ming‐Kuei Jang, Bradford Navia	6
6	Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607 2021 ·Acta Neuropathologica ·Yue‐De Yang, Alexey G. Murzin, Benjamin Falcon, (unknown), Jonathan Machin, Paul Tempest, Kathy L. Newell, Rubén Vidal, Holly J. Garringer, Naruhiko Sahara, Makoto Higuchi, Bernardino Ghetti, Ming‐Kuei Jang, Sjors H. W. Scheres, Michel Goedert	127
7	Clinical Utility of ¹⁸F‐APN‐1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy 2021 ·Movement Disorders ·Ling Li, Fengtao Liu, Ming Li, Jiaying Lu, Yi‐Min Sun, Xiaoniu Liang, Weiqi Bao, (unknown), Xinyi Li, (unknown), Yihui Guan, Jian Wu, Tzu‐Chen Yen, Ming‐Kuei Jang, Jianfeng Luo, Jian Wang, Chuantao Zuo, (unknown)	62
8	Characterization of 18F-PM-PBB3 (18F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy 2020 ·Molecules ·Chi-Chang Weng, Ing‐Tsung Hsiao, (unknown), (unknown), Chin‐Yin Tai, Meng‐Fang Wu, Tzu‐Chen Yen, Ming‐Kuei Jang, Kun‐Ju Lin	32
9	The Imaging Features and Clinical Associations of a Novel Tau PET Tracer—18F-APN1607 in Alzheimer Disease 2020 ·Clinical Nuclear Medicine ·Jung‐Lung Hsu, Kun‐Ju Lin, Ing‐Tsung Hsiao, Kuo‐Lun Huang, Chi‐Hung Liu, Hsiu-Chuan Wu, Yi‐Ching Weng, (unknown), Chiung‐Chih Chang, Tzu‐Chen Yen, Makoto Higuchi, Ming‐Kuei Jang, Chin‐Chang Huang	26
10	Synaptically preferred anti‐tau antibodies reduce in vitro tau seeding and in vivo neuronal loss 2020 ·Alzheimer s & Dementia ·Chin‐Yin Tai, (unknown), Sheng‐Chieh Huang, (unknown), Meng‐Fang Wu, Chia‐Lin Wu, Ming‐Kuei Jang	0
11	In vivo axonal transport deficits in a mouse model of fronto-temporal dementia 2014 ·NeuroImage Clinical ·(unknown), Yousuf Ali, Deepa V. Venkitaramani, Ming‐Kuei Jang, Hui‐Chen Lu, Robia G. Pautler	56
12	The Neuroactive Steroid Pregnenolone Sulfate Stimulates Trafficking of Functional N-Methyl D-Aspartate Receptors to the Cell Surface via a Noncanonical, G Protein, and Ca2+-Dependent Mechanism 2013 ·Molecular Pharmacology ·(unknown), Conor Smith, Ming‐Kuei Jang, Stella C. Martin, (unknown), Shelley J. Russek, Terrell T. Gibbs, David H. Farb	33
13	A steroid modulatory domain in NR2A collaborates with NR1 exon‐5 to control NMDAR modulation by pregnenolone sulfate and protons 2011 ·Journal of Neurochemistry ·(unknown), Ming‐Kuei Jang, Shelley J. Russek, Terrell T. Gibbs, David H. Farb	26
14	A steroid modulatory domain on NR2B controlsN-methyl-d-aspartate receptor proton sensitivity 2004 ·Proceedings of the National Academy of Sciences ·Ming‐Kuei Jang, Dale F. Mierke, Shelley J. Russek, David H. Farb	81
15	Facile Amide Bond Formation From Esters of Amino Acids and Peptides Catalyzed by Alkaline Protease in Anhydroustert-Butyl Alcohol Using Ammonium Chloride/Triethylamine as a Source of Nucleophilic Ammonia 1993 ·Synthesis ·Shui‐Tein Chen, Ming‐Kuei Jang, Kung‐Tsung Wang	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact